New shot could help diabetics lose weight and lower blood sugar
NCT ID NCT05110846
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new daily injection called CT-868 in 103 overweight or obese adults with type 2 diabetes. Participants received either the drug or a placebo for 26 weeks. The main goal was to see if CT-868 could lower blood sugar levels (HbA1c) and help with weight loss.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CT-868 (a once-daily injection)
- What this could lead to
- If successful, this could point toward a new daily injection that helps control blood sugar and reduce weight in people with type 2 diabetes.
- What could go wrong
- This is a Phase 2 trial with only 103 participants, so results may not apply to everyone. The drug is still experimental and may not prove better than existing treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Carmot Clinical Center MX01
Monterrey, Nuevo León, Mexico
-
Carmot Clinical Center MX02
Monterrey, Nuevo León, Mexico
-
Carmot Clinical Center MX03
Mexico City, Mexico
-
Carmot Clinical Center MX04
Guadalajara, Jalisco, Mexico
-
Carmot Clinical Center MX05
Mérida, Yucatán, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- Could the speed of blood sugar drop harm the eyes? a study puts it to the test.
- Fig leaf tea may shield kidneys from diabetes damage — a trial puts it to the test